CAC 40
7.979,92
PKT
-76,46
PKT
-0,95
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu CAC 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.01.23 | Kering Neutral | UBS AG | |
| 09.01.23 | EssilorLuxottica Buy | UBS AG | |
| 09.01.23 | Sanofi Neutral | UBS AG | |
| 09.01.23 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 09.01.23 | Air Liquide Outperform | Bernstein Research | |
| 06.01.23 | STMicroelectronics Underperform | Jefferies & Company Inc. | |
| 06.01.23 | Sanofi Outperform | Credit Suisse Group | |
| 06.01.23 | Sanofi Equal-weight | Morgan Stanley | |
| 06.01.23 | Alstom Overweight | JP Morgan Chase & Co. | |
| 05.01.23 | Alstom Buy | Deutsche Bank AG | |
| 05.01.23 | EssilorLuxottica Outperform | Bernstein Research | |
| 05.01.23 | Kering Outperform | Bernstein Research | |
| 05.01.23 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 05.01.23 | Pernod Ricard Overweight | Barclays Capital | |
| 05.01.23 | Air Liquide Buy | UBS AG | |
| 05.01.23 | Schneider Electric Buy | Deutsche Bank AG | |
| 05.01.23 | LVMH Moet Hennessy Louis Vuitton Overweight | Barclays Capital | |
| 05.01.23 | Kering Equal Weight | Barclays Capital | |
| 05.01.23 | Hermès (Hermes International) Overweight | Barclays Capital | |
| 05.01.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 04.01.23 | Pernod Ricard Outperform | Credit Suisse Group | |
| 04.01.23 | Pernod Ricard Buy | Goldman Sachs Group Inc. | |
| 04.01.23 | Sanofi Hold | Deutsche Bank AG | |
| 04.01.23 | Pernod Ricard Hold | Deutsche Bank AG | |
| 04.01.23 | Air Liquide Outperform | Bernstein Research | |
| 04.01.23 | Schneider Electric Outperform | Bernstein Research | |
| 03.01.23 | Valeo SA Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Stellantis Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Renault Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | BNP Paribas Buy | Jefferies & Company Inc. | |
| 03.01.23 | SAFRAN Hold | Jefferies & Company Inc. | |
| 03.01.23 | Airbus Buy | Jefferies & Company Inc. | |
| 02.01.23 | Valeo SA Overweight | JP Morgan Chase & Co. | |
| 28.12.22 | Airbus Overweight | Barclays Capital | |
| 23.12.22 | Sanofi Equal Weight | Barclays Capital | |
| 21.12.22 | BNP Paribas Outperform | RBC Capital Markets | |
| 20.12.22 | SAFRAN Hold | Jefferies & Company Inc. | |
| 20.12.22 | Airbus Buy | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.